Why AI matters at this scale

EyeCare Partners (formerly CVP) is one of the nation's leading providers of clinically integrated eye care, operating a vast network of ophthalmology and optometry practices. Founded in 2015 and headquartered in Cincinnati, Ohio, the company has grown rapidly to employ between 5,001 and 10,000 professionals. It functions as a management services organization, supporting hundreds of doctors across multiple states by handling administrative, technological, and strategic functions, allowing physicians to focus on patient care. Their scale creates a unique platform for standardizing care delivery and leveraging data across a massive patient base.

For an organization of this size and structure, AI is not a futuristic concept but a practical tool for addressing core challenges of scale: operational efficiency, diagnostic consistency, and personalized care. The network generates enormous volumes of structured and unstructured data—from electronic health records (EHRs) and diagnostic imaging to scheduling logs. At this employee band, manual processes and data silos become significant cost centers and barriers to growth. AI offers the capability to unify insights from this data, automate repetitive tasks, and augment clinical decision-making, directly impacting patient outcomes and the bottom line.

Concrete AI Opportunities with ROI Framing

1. Diagnostic Imaging Augmentation: Deploying FDA-cleared AI for automated analysis of optical coherence tomography (OCT) and retinal images can screen for conditions like diabetic retinopathy. This reduces the burden on specialists for initial reviews, allows technicians to handle more patients, and enables earlier intervention. The ROI includes new revenue from expanded screening services, reduced liability from missed diagnoses, and improved patient retention through advanced care.

2. Operational Workflow Optimization: Implementing predictive AI for patient scheduling can forecast no-shows and optimize physician and equipment time across dozens of locations. This directly increases revenue per clinic by filling last-minute cancellations and reduces administrative labor. For a network of this scale, a few percentage points of improved utilization translate to millions in recovered revenue annually.

3. Personalized Treatment and Predictive Analytics: Machine learning models can analyze historical surgical outcomes, patient demographics, and pre-operative data to predict optimal intraocular lens (IOL) power for cataract surgery or identify patients at high risk for glaucoma progression. This improves surgical success rates, reduces costly re-operations, and enables proactive care management, enhancing patient satisfaction and clinical reputation.

Deployment Risks Specific to This Size Band

Deploying AI across a 5,000–10,000 employee network presents distinct risks. Data Integration Complexity is paramount; consolidating data from multiple, potentially incompatible EHR systems across acquired practices is a massive technical and project management hurdle. Change Management at this scale is daunting; convincing hundreds of independent-minded physicians to adopt and trust AI-driven workflows requires careful communication, training, and demonstrated clinical validity. Regulatory and Compliance Risk is heightened; any AI tool must be meticulously vetted for HIPAA compliance and medical device regulations, and a breach or regulatory misstep could impact the entire network. Finally, Vendor Lock-in and Cost pose financial risks; large-scale contracts with AI SaaS vendors can become inflexible and expensive, necessitating a clear strategic vision and strong governance to ensure investments deliver tangible returns.